Research & Development

彩票app排名榜下载app送20的彩票手机投注彩票app下载北京东四环一小区旁现大片墓地 民政部门介入调查


  黎江眼珠轉了一下,道︰“哥哥呢?”   黎江︰哥哥,以後我們倆住在……彩票app排名榜   還有一個月?下载app送20的彩票   “啊哈哈,要低調,低調!我這個人喜歡低調!”劉莽強行撐了一波面子,總不能說那車是別的女人的吧!   第一次是艾弗森,第二次是麥迪,這次和卡特居然也五五開!手机投注彩票app下载   “艾斯你真是個大好人!等哥們兒將來成了大明星一定報答你!好兄弟一輩子!”小比伯默默的發出了劉莽想要淚奔的誓言……

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo